Kan Liu

No ORCID on file · 1 paper in corpus
nonrandomized-trial 2024
Therapeutic advances in medical oncology ·doi:10.1177/17588359241307818

BACKGROUND: A newly generic microspheres, sustained-release formulation of triptorelin acetate 3.75 mg has been developed. OBJECTIVES: To evaluate the efficacy, pharmacokinetics, and safety of triptorelin 1-month formulation in Chinese pat…